Physician profile
Eric Shaw
NPI 1336569250
$1,349.59
in general payments reported to CMS, 2019-2025
17 companies · $454 in 2025
The $454 reported for 2025 was more than what 77% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85.30 · 2020: $199 · 2021: $35.49 · 2022: $158 · 2023: $270 · 2024: $148 · 2025: $454.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $851 · Education: $21.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $850.68 |
| Education | $21.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $245.07 | 2023-2024 | Prolaris |
| Boston Scientific Corporation | $204.87 | 2021-2025 | Accolade Sr |
| Urogen Pharma, INC. | $188.12 | 2024-2025 | |
| Dendreon Pharmaceuticals LLC | $139.86 | 2020 | |
| Astellas Pharma US INC | $124.29 | 2019-2022 | |
| Olympus America INC. | $66.59 | 2025 | Itind System |
| Pfizer INC. | $53.50 | 2022-2024 | |
| Ferring Pharmaceuticals INC. | $53.20 | 2024-2025 | Adstiladrin |
| Smith+Nephew, INC. | $43.52 | 2020 | |
| Progenics Pharmaceuticals, INC. | $42.46 | 2023-2024 | Pylarify |
| 180 Medical, INC. | $41.64 | 2022-2025 | |
| Coloplast Corp | $33.90 | 2019 | |
| Therapeuticsmd, INC. | $29.08 | 2019-2020 | |
| Telix Pharmaceuticals | $28.61 | 2024 | Illuccix |
| Merck Sharp & Dohme LLC | $22.38 | 2025 | Keytruda |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $19.95 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.55 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Shaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.